Company Email Format Management

Ambys Medicines

Biotechnology Research 131 Oyster Point Blvd 14 employees

Employees: 14
Contacts: 4
Emails: 4
Phones: 2

ambys.com LinkedIn Crunchbase

Ambys Medicines Overview

Headquarters: 131 Oyster Point Blvd
Phone Number: Available in AeroLeads
Website: ambys.com
Industry: Biotechnology Research
Employees: 14
Founded: 2018
Funding: 47.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Ambys Medicines

Ambys Medicines is focused on unlocking the full potential of hepatocyte transplantation and transforming the treatment of severe liver disease. Ambys’ proprietary cell therapy platform potentially solves the supply constraints that have hindered progress, catalyzing the field and fundamentally transforming the approach to treating severe liver disease. Our lead program, AMI-918, and future engineered hepatocyte cell therapies are being developed across the spectrum of severe liver disease, including those of acquired and genetic origins.

Ambys Medicines Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Ambys Medicines Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rhonda Wiler, Dvm, Daclam	Vice President - in Vivo Technical Ops	Davis, California, United States	Email
John Mckeon, Cpa	VP Finance and Controller at Ambys	San Francisco, California, United States	Email Phone
Abeba Demelash Ph.d.	Senior Scientist I at Merck	San Francisco, California, United States	Email Phone
Priyadarshini Podishetti	Quality Engineer at Ambys	San Francisco Bay Area, United States	Email